TP53 and hepatocellular carcinoma: Similarly, research on two pairs of HCC patients revealed that BLCAP transcript is hyper-edited, which will enhance the phosphorylation of AKT, MTOR, and MDM2 and inhibit the function of TP53, thus promote cell proliferation and tumor development (18).